Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?
PaperCitations, authors & open-access status
Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor? is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 67 citations, 2018 year and closed oa status.
67
Citations
2018
Year
closed
OA Status